Medicover AB (publ) ("Medicover") publishes the nomination committee's composition for the annual general meeting in 2022.
The Board of Medicover AB (publ)
For more information, please visit:medicover.com (https://www.medicover.com/financial-information/corporate-governance/nomination-committee)
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting to be held on 27 April 2022 can do so by e-mail to
Att: Nomination Committee/General Legal Counsel
Box 5283, 102 46 Stockholm, Sweden
Proposals should be submitted to the nomination committee at latest on 9 March 2022.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities,laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2020, Medicover had revenue of EUR 998 million and more than 32,000 employees. For more information, go to www.medicover.com